| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | E9N7QV53AK |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C65H91N17O16PbS2 |
| Molecular Weight | 1642.67 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neuroendocrine Tumors | 1 | D018358 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297347 |
| FDA SRS | E9N7QV53AK |
CONTENTS